Page 8 - Magenta Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Magenta therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Magenta Therapeutics Today - Breaking & Trending Today

Magenta Therapeutics, Inc. (NASDAQ:MGTA) Expected to Post Q2 2023 Earnings of ($0.19) Per Share

Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) – Stock analysts at Wedbush boosted their Q2 2023 earnings per share (EPS) estimates for Magenta Therapeutics in a research report issued on Tuesday, May 16th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings per share of ($0.19) for the quarter, up from their […] ....

United Kingdom , Luigi Naldini , Johnf Dipersio , Alan Tyndall , Davidt Scadden , Robert Negrin , Derrickj Rossi , Citadel Advisors , Magenta Therapeutics Inc , Magenta Therapeutics Company Profile , Acadian Asset Management , Walleye Capital , Magenta Therapeutics , Get Rating , Magenta Therapeutic , Therapeutics Stock Down , Asset Management , Jason Gardner , Magenta Therapeutics Daily , Nasdaq Mgta , Earnings Estimates ,

Moore Kuehn Encourages MGTA, HSKA, RUTH and SYNH Investors

NEW YORK, May 10, 2023 (GLOBE NEWSWIRE) Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York. ....

New York , United States , Moore Kuehn , Justin Kuehn , Syneos Health Inc , Darden Restaurants , Heska Corporation , Ruth Hospitality Group Inc , Syneos Health , Ruth Hospitality Group , Mars Incorporated , Magenta Therapeutics Inc , Wall Street , New York City , Hospitality Group , Magenta Therapeutics , Uths Hospitality , Lass Action ,

Magenta and Dianthus unveil merger, creating next-gen autoimmune therapeutics powerhouse

The combined company will operate under the Dianthus Therapeutics name, and focus on advancing its lead candidate, DNTH103. ....

Marino Garcio , Steve Mahoney , Magenta Therapeutics , Dianthus Therapeutics , Cold Agglutinin Disease ,

Magenta Therapeutics, Inc. (NASDAQ:MGTA) Sees Significant Drop in Short Interest

Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) was the recipient of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 1,060,000 shares, a drop of 10.9% from the March 31st total of 1,190,000 shares. Currently, 2.4% of the company’s shares are short sold. Based […] ....

United Kingdom , Davidt Scadden , Alan Tyndall , Robert Negrin , Luigi Naldini , Johnf Dipersio , Derrickj Rossi , Thrivent Financial For Lutherans , Morgan Stanley , Renaissance Technologies , Millennium Management , Magenta Therapeutics Inc , Magenta Therapeutics , Get Rating , Sigma Investments , Thrivent Financial , Jason Gardner , Magenta Therapeutics Daily , Nasdaq Mgta ,

Magenta agrees to reverse merger with Dianthus after setbacks

BioPharma ....

Marino Garcia , Argenx Vyvgart , Magenta Therapeutics , Dianthus Therapeutics ,